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Abstract.  In an effort to determine diversity and func- 
tion of mammalian  myosin I molecules, we report here 
the cloning and characterization  of myr 3 (third  uncon- 
ventional myosin from rat),  a novel mammalian myo- 
sin I from rat tissues that is related to myosin I mole- 
cules from protozoa.  Like the protozoan myosin I 
molecules, myr 3 consists of a myosin head dOmain,  a 
single light chain binding motif, and a tail region that 
includes a COOH-terminal SH3 domain.  However, 
myr 3 lacks the regulatory phosphorylation site pres- 
ent in the head domain of protozoan myosin I mole- 
cules.  Evidence was obtained that the COOH terminus 
of the tail domain is involved in regulating  F-actin 
binding activity of the NH2-terminal head domain. 
The light chain of myr 3 was identified as the Ca  2+- 
binding protein calmodulin.  Northern blot and immu- 
noblot analyses revealed that myr 3 is expressed in 
many tissues and cell lines.  Immunofluorescence 
studies with anti-myr 3 antibodies in NRK cells dem- 
onstrated that myr 3 is localized in the cytoplasm and 
in elongated structures at regions of cell-cell contact. 
These elongated structures contained F-actin and 
o~-actinin but were devoid of vinculin.  Incubation of 
NRK cells with Con A  stimulated the formation of 
myr 3-containing  structures along cell-cell contacts. 
These results suggest for myr 3 a function mediated 
by cell-cell contact. 
M 
YOSIN I  molecules represent  a  subfamily  of the 
rapidly expanding myosin superfamily.  Like con- 
ventional muscle myosin (myosin II), they exhibit 
an NH2-terminal head region, a light chain binding  region, 
and a COOH-terminal tail region.  The head region is rela- 
tively well conserved in all myosins; it comprises ATP- and 
actin-binding sites and exhibits actin-activated ATPase activ- 
ity (Pollard  et al.,  1991). The head  region  and  the light 
chain-binding region with the associated light chain(s)  are 
sufficient  to produce directed force along  actin  filaments 
(Toyoshima et al., 1987). The tail regions of myosin I mole- 
cules,  in contrast to the tail regions of conventional  muscle 
myosin (myosin II), do not dimerize  or form filaments.  For 
some of the myosin I tails, it has been demonstrated that they 
bind to membranes (Adams and Pollard,  1989; Miyata et al., 
1989; Hayden et al.,  1990). All myosin I tails share a diag- 
nostic  myosin  I  tail  homology motif possibly involved  in 
membrane binding (Btihler et al., 1994). A subgroup of myo- 
sin  I  molecules ("amoeboid")  identified  in Acanthamoeba 
castellanii and Dictyostelium discoideum contain in their tail 
regions  a Src homology 3 (SH3) domain.  This  domain is 
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found in many cytoskeletal and signaling  molecules and is 
thought to represent a regulatory protein-protein interaction 
motif (Pawson and Schlessinger,  1992). 
The amoeboid myosin I subgroup represents the best stud- 
ied of the myosin I molecules.  Their actin-activated  ATPase 
activity  and motility  are activated  by phosphorylation of a 
single serine/threonine  residue in the head region.  The light 
chains  associated with  the amoeboid myosin  I  molecules 
have  not been well  characterized,  and  it  is  currently not 
known whether they confer additional  regulation  on motor 
activity. Other myosins,  including  myosin I molecules, are 
known to be regulated via their light chains (Collins et al., 
1990). 
Localization  studies in Acanthamoeba provided  evidence 
that myosin I molecules are associated with different intra- 
cellular  membranes  (Gadasi  and  Korn,  1980;  Baines  and 
Korn,  1990;  Baines  et al.,  1992; Yonemura  and  Pollard, 
1992),  whereas localization  studies  in Dictyostelium pro- 
vided evidence that  myosin  I  molecules are concentrated 
in cortical  actin-rich  structures,  such as leading edge pseu- 
dopods and phagocytic cups (Fukui et al., 1989; Jung et al., 
1993). Antibody inhibition  of myosin IC in Acanthamoeba 
demonstrated  a role for this myosin I in contractile  vacuole 
function  (Doberstein et al.,  1993). Deletions of myosin IA 
or IB  in Dictyostelium by homologous recombination  re- 
sulted in only subtle phenotypes revealing no clear clue as 
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et al., 1993; Jung and Hammer, 1990; Wessels et al., 1991). 
If the amoeboid myosin I molecules play general roles in 
intraceUular trafficking of membranes with respect to actin 
filaments as proposed (Pollard et al., 1991), then these myo- 
sins  should  not be  restricted to  protozoa.  To  determine 
whether such myosin I molecules are involved in aspects of 
membrane traffic in metazoa, we initiated a search for such 
molecules in mammalian (rat) tissues.  Here we report the 
identification of an amoeboid-type myosin I  from rat.  We 
identified its light chain as calmodulin and demonstrate that 
this molecule, designated third unconventional myosin from 
rat (myr 3), t is concentrated in cortical actin-rich structures 
at sites of cell-cell contact. Such structures can be induced 
at sites of cell-cell contact by application of Con A. A pre- 
liminary account of this work has been published in abstract 
form (Sttffler, H.-E., J. Reinhard, C. Ruppert, and M. Biih- 
ler.  1993. Mol. Biol. Cell. 4:(Suppl.)39a). 
Materials and Methods 
Primers and PCR Amplification 
PCR was performed with the degenerate oligonucleotides  MBI1  (sense) 
5'-ACOOATCCGGIGCIGGIAA(A/G)ACIGA(A/G)GC-Y,  MB  20  (anti- 
sense)  5'-CAOAATTCAA(C/T)TCIAT(A/O)TCCAT(O/A)TA(T/C)TT- 
ICC-3'~ MB  13  (antisense)  5'-ACGGATCCIA(G/A)(T/C)TG(G/A)TA(G/ 
A)AA(T/G/A)AT(G/A)TG(G/A)AA-3',  and MB  14 (sense)  5'-TCGAAT- 
TCOA(A/G)GCITT(C/T)GGIAA(C/T)GCIAA-3'  as described by Ruppert 
et al. (1993). MB 11 was derived from the amino acid sequence GAKTEA, 
MB  20  from  GKYMEIQE  MBI3  from  FHIFYQL,  and MB  14  from 
EAFGNAK. 
Library Screening 
A ~ ZAP II rat brainstem/spinal cord eDNA library (Stratagene,  La Jolla, 
CA) was screened with a  145-bp PCR fragment (11/20-13) corresponding 
to nucloatides  609-754 of myr 2 (Ruppert,  C., £  Godel, I. Reinhard, and 
M. Biihler, accession  number X74800) according to standard procedures. 
Several  clones  were  isolated out  of 2  ×  106  recombinants screened. 
pBluescript  SK plasmids were excised from k ZAP II clones according to 
the instructions of the supplier. Clone 33-1, which hybridized with a myr 3 
PCR fragment (13/14-1) previously obtained using primers MB 13 and MB 
14, was completely  sequenced. 
DNA Sequencing 
Nucleotide  sequences  were  determined by the method of Sanger et al. 
(1977) using double-stranded DNA templates and the Sequenase version 2.0 
kit (United States Biochemicals  Corp., Cleveland, OH). For sequencing, 
a series of nested  deletions were constructed by the method of Henikoff 
(1987) with the Erase-a-Base  kit (Promega Corp., Madison, WI). The se- 
quence was determined for both strands. Sequence analysis was performed 
with the PC/Gene (IntelliOenetics,  Mountain View, CA) and the University 
of Wisconsin  Oenetics Computer Group (UWGCG version 7)  software 
packages (Devereux et al.,  1984). 
RNA Purification and Northern Blot Analysis 
Total RNA was prepared according to the method of Chirgwin et al. (1979), 
and poly(A)+RNA was isolated using the PolyATract mRNA isolation sys- 
tem (Promega  Corp.).  For Northern blot analysis,  poly(A)*  RNA was 
electrophoresed  in 1% agarose  gels containing 2.2 M  formaldehyde  and 
transferred onto Hybond-N nylon membranes (Amersham Buchler OmbH, 
Braunschweig,  FRO).  The filters  were  prehybridized  and hybridized at 
42°C in 50% formamide,  5× SSC, 50 mM sodium phosphate, pH 7, 0.5% 
SDS, 0.1 mg/ml poly(A) (Boehringer OmbH, Mannheim, FRO), and 0.25 
1. Abbreviationa used in this paper: myr 3, third unconventional  myosin 
from rat; SH3, Src homology  3. 
mg/ml denatured salmon sperm DNA. DNA probes were labeled using a 
random primer labeling kit (Boehringer GmbH). Filters were washed (2 × 
SSC, 0.1% SDS at room temperature, 2  ×  30 min; 2× SSC, 0.1% SDS at 
65°C,  l0 min) and exposed to X-Groat AR film (Eastman Kodak Co., Roch- 
ester, NY) at -70°C with an intensifying  screen (Cronex Quanta HI, Du 
Pont, Wilmington, DE). 
Antibodies 
To raise specific antibodies against myr 3, peptide  1, MEEHPELQQFVG- 
KREKID  (corresponding  to  amino  acids  748-765),  and  peptide  2, 
RQMDSKWGGKSESIHVT (corresponding to amino acids 326-342), were 
synthesized.  For selective coupling to a carrier protein, a cysteine residue 
was added to each peptide at the COOH terminus. The peptides were cou- 
pled to keyhole limpet hemocyanin (Calbiochem-Behring Co., San Diego, 
CA) with m-maleimidobenzoyl  suifosuccinimide  ester (Pierce,  Rockford, 
IL) according to Green et al. (1982) and injected into rabbits using standard 
immunization  protocols.  The resulting antisera (peptide  1: Tii 41; peptide 
2: TO 57 and Tfi 58) were affinity purified over the respective peptides cou- 
pled to CNBr-activated  Sepharose 4B (Pharmacia, Freiburg,  FRG) accord- 
ing to the instructions of the manufacturer. 
Antisera FML 5 and FML 6 were raised against fusion protein $2 (en- 
compassing amino acids 821-1107). Fusion protein $2 was constructed by 
cloning the BamHI-Hindl]I fragment of clone 33-1 into the His-tag pQE32 
vector (Qiagen,  Hilden,  FRO).  The bact¢riai fusion protein was affinity 
purified  under denaturing conditions over Ni-NTA  resin (Qiagen)  as de- 
scribed by the manufacturer and injected into rabbits. Antisera were affinity 
purified over fusion protein $2 coupled to CNBr-activated  $epharose 4B. 
To obtain antibodies directed specifically  against the SH3  domain of 
myr 3, antiserum FML 5 was passed over the GST-SH3 fusion protein cou- 
pled to CNBr-activated  Sepharose  4B. The eDNA encoding the SH3 do- 
main (amino acids  1057-1105) was  amplified  by PCR and cloned over 
BamHI and EcoRI restriction sites into the pGEX-3X vector (Pharmacia). 
lmmunoblotting 
Immunoblotting was performed according to Towbin et al. (1979). Primary 
antibodies were diluted in 5% nonfat dry milk to 2/,g/ml. Alkaline phos- 
phatase-coupled secondary antibody was diluted in 5 % nonfat dry milk and 
0.1% Triton X-100. The phosphatase reaction was visualized by the Proto- 
Blot system (Promega  Corp.). 
Immunoblotting of caimodulin was performed according to Hulen et ai. 
(1991) with slight modifications. Before elcctrotransfer,  the SDS gel and the 
methanol-treated  Immobilon P membrane (Millipore Corp., Molford, MA) 
were incubated for 15 min in KP buffer (50 mM potassium phosphate, pH 
7.0). After the transfer (4°C,  20 V,  12 h, KP buffer),  the membrane was 
rinsed in PBS, fixed for 45 rain with 0.2% glutaraldehyde  in KP buffer, and 
rinsed again in PBS. The membrane was blocked for 1 h in PBS, 2 % BSA, 
0.1% gelatin.  The anti-calmodulin antibody (Sigma,  Deisenhofcn, FRG) 
was diluted in PBS; the peroxidase-coupled  secondary antibody was diluted 
in PBS, 0.05% Twin 20. The peroxidase  reaction was visualized  by the 
ECL system (Amersham Buchler OmbH). 
Immunoprecipitation 
Lung tissue of adult rats was homogenized in 0.32 M sucrose, 5 mM Hepes, 
pH 7.4 (1:5 [wt/vol]),  and centrifuged  in a SS-34 rotor at 16,000 rpm for 
40 rain.  1 ml of the supernatant was incubated for 40 rain on ice with 10 
#g of affinity-purified anti-myr 3 antibody. After addition of  40 #l of protein 
A-Sepharose 4B (Pharmacia), the mixture was rotated at 4°C for 30 min. 
The beads were washed three times with TBS (150 mM NaCI 50 mM Tris- 
HCI, pH 7.4), and bound proteins were eluted by adding 5 #1 ofS×  SDS 
buffer and boiling for 5 min. 
Calmodulin Binding Assay 
Calmodulin gel overlays were performed in the presence and absence of free 
Ca  2+ (0.1 mM CaCI2 and 3  mM  EGTA,  respectively)  as described by 
Slaughter and Means (1987).  12~I-labeled  calmodulin was purchased from 
New England Nuclear (Dreieich, FRO). 
lmmunofluorescence 
For  indirect  immunofluomscence,  cells  were  cultured  on  coverslips 
pretreated with poly-L-lysine and fixed in 4 % paraformaldehyde  in PBS. Af- 
ter quenching with 0.1 M glycine in PBS, the cells were pcrmnabilized for 
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ondary antibodies were appropriately diluted in 5 % normal goat serum in 
PBS. Monoclonal antibodies directed against ct-actinin and vinculin were 
purchased from Sigma. Secondary goat anti-rabbit antibodies coupled to 
rhodamine and goat anti-mouse antibodies coupled to  FITC  were  pur- 
chased from Dianova (Hamburg, FRG), FITC-coupled phalloidin was from 
Molecular Probes, Inc. (Eugene, OR). To remove free antibodies, the cells 
were rinsed several times with PBS and then mounted (15%  Mowiol 4-88 
(Hoechst, Frankfurt, FRG),  30%  glycerol in PBS, pH 8). 
Miscellaneous Techniques 
Gel electrophoresis was performed according to Laemmli (1970). Cell lines 
were  grown  as  described  by  Biihler et  al.  (1994).  Rat  lung tissue was 
homogenized  and extracted as described, and binding to F-actin was assayed 
by. cosedimentation experiments (Ruppert et al,,  1993), 
Results 
Isolation of the Myr 3 cDNA 
To identify unconventional myosins expressed in rat brain 
tissue, PCR amplification of myosin-like sequences was per- 
formed. Using degenerate oligonucleotide primers derived 
from  conserved  sequences  in  the  myosin  head  region 
(GAGKTEA and GKYMDIE), a cDNA fragment coding for 
a putative myosin was obtained.  Screening of a  rat brain- 
stem/spinal  cord cDNA library with this cDNA fragment 
led to the identification of several positive clones, encoding 
four different unconventional myosins (Reinhard, J., A. A. 
Scheel, C. Ruppert, and M. Biihler.  1993. Mol.  Biol.  Cell. 
4:[Suppl.] 40a). One of these clones (33/1; 4.3 kb) strongly 
hybridized to a cDNA fragment obtained by PCR amplifica- 
tion using primers coding for two different conserved myosin 
sequences (EAFGNAK and FHIFYQL). This clone, which 
seemed to encode a novel unconventional myosin, was sub- 
jected to  DNA  sequencing.  It exhibited an open reading 
frame of 3321  bp coding for a protein of 1107 amino acids 
(Fig.  1). The start of the open reading frame contained the 
consensus translation initiation sequence described by Ko- 
zak (1991). Sequence analysis of the deduced amino acid se- 
quence  revealed  an  NH:-terminal  myosin  head  domain 
(amino acids  1-698),  a single putative light chain-binding 
site (amino acids 699-722), and a COOH-terminal tail do- 
main  (amino  acids  723-1107)  (Fig.  2).  This  myosin  was 
termed myr 3. 
Myr 3 Is Related to Myosin I Molecules from Protozoa 
Sequence comparison revealed that myr 3 is most similar to 
human myosin IC (Bement et al., 1994b) (95 % identity) and 
chicken BBMIB (Knight, A. E., and J. Kendrick-Jones, ac- 
cession no. X70400) (73 % identity). These three vertebrate 
myosin I molecules were closely related to myosin I mole- 
cules previously characterized in protozoa. Compared with 
myosin I  molecules identified from protozoa,  myr 3  was 
most similar in sequence and structural organization to myo- 
sin IB molecules from A. castellanii (Jung et al., 1989b) and 
D.  discoideum  (Jung et al.,  1989a) (Fig. 2). 
Similar to myosin IB molecules from Dictyostelium  and 
Acanthamoeba,  the myr 3 motor domain contains a myosin 
head region (55-57% identity) and only a single IQ motif, 
which represents a putative light chain-binding site (Figs.  1 
and 2). However, in contrast to the myosin I molecules from 
protozoa, myr 3 is lacking the consensus sequence for phos- 
phorylation in the head region (Fig.  3 A). Phosphorylation 
~  ~ ~ . 
Figure 1.  Nucleotide and deduced amino acid sequences of the 
myr 3 cDNA. The amino acid sequence of myr 3 is shown below 
the nucleotide sequence. The nucleotides of the start codon at posi- 
tions 287-289 and the amino acids encompassing the putative light 
chain-binding region are underlined. Boldfaced amino acids indi- 
cate the COOH-terminal SH3 domain. The nucleotide sequence 
data are accessible through the EMBL nucleotide sequence data- 
base under the accession number X74815. 
at this site is needed for actin-activated ATPase activity and 
force production in myosin I molecules from protozoa. In- 
stead, myr 3 exhibits at the corresponding position a nega- 
tively charged amino acid, as is also found in myosin II from 
skeletal muscle, which is constitutively active. 
Figure 2. Comparison of the overall structure of myr 3 and myosin 
IB from A. castellanii. Schematic drawings of the heavy chains are 
shown. IQ motifs are in light gray, the tail homology regions are 
in dark gray, the SH3 domains are in black, and the GPA-rich  region 
in Acanthamoeba myosin IB is crosshatched. The phosphorylation 
site in Acanthamoeba myosin IB is indicated (P). The myosin head 
domain, the single IQ motif, and the tail region are indicated above 
the drawing. Ac MIB, A. castellanii myosin IB (Jung et al., 1989b). 
St6ffier et al.  Mammalian Myosin 1  821 Figure 3.  (A) Alignment of myosin head amino acid sequences encompassing the phosphorylation site of amoeboid myosin I molecules. 
Similar residues are on a light gray background. The arrow points to the serine residue that becomes phosphorylated in myosins IB and 
IC ofA. castellanii. The serine residues are rendered in white against a dark gray background, and the glutamic acid residues at the corre- 
sponding positions in the vertebrate myosins in white against a black background. The numbers refer to the position of the first displayed 
amino acid. Gg BBMIB, chicken brush border myosin IB (Knight, A. E., and J. Kendrick-Jones, accession number X70400); Gg myosin 
H, conventional myosin II from chicken fast skeletal muscle (Molina et al.,  1987); Ac MIB, A. castellanii myosin 113 (Jung et al.,  1989b); 
Ac MIC, A. castellanii myosin IC (Jung et al., 1987). (B) Alignment of the myr 3 SH3 domain amino acid sequence with closely related 
SH3 domains. Similar residues are shaded with a gray background. The numbers refer to the position of the first displayed amino acid. 
Gg BBMIB, chicken brush border myosin IB (Knight and Kendrick-Jones, accession number X70400); Ac MIB, A. castellanii myosin IB 
(Jung et al.,  1989b); DdMIB, D. discoideum myosin IB (Jung et al.,  1989a); Sc rvs167, yeast rvs167 (Bauer et al., 1993); Hs HS1, human 
hematopoietic lineage cell-specific protein 1 (Kitamura et al., 1989); Gg Cortactin, chicken cortactin (p80/85) (Wu et al., 1991); Hs GRB2, 
human growth factor receptor-bound  protein 2 (Lowenstein et al.,  1992; Matuoka et al.,  1992). 
The tail domain of myr 3 shares 33-34 % sequence identity 
with the tail domains of Acanthamoeba  and Dictyostelium 
myosin IB. As in these protozoan myosin molecules, the my- 
osin I tail homology motif, as defined by B~ihler et al. (1994), 
is  found at the NH2 terminus of the tail domain,  and the 
second and third blocks of conserved residues are separated 
by a highly charged insertion. The relative position and sub- 
division of this motif represent further diagnostic criteria for 
subclassification of myosin I  proteins.  Unlike the tail do- 
mains of the protozoan myosin I molecules, the myr 3 tail 
does not contain an extended region rich in GPA/Q.  How- 
ever, it exhibits a short stretch of PK/Q dipeptide repeats. At 
its COOH terminus, following this dipeptide repeat, myr 3 
has an SH3 domain (Fig. 3 B). This domain is found in many 
proteins that are involved in cell signaling and/or interact 
with the actin cytoskeleton (Pawson and Schlessinger,  1992). 
It is thought to represent a protein-protein interaction motif. 
The myr 3 SH3 domain is most similar to the SH3 domains 
found in myosin I molecules from protozoa, other cytoskele- 
tal proteins, and the COOH-terminal SH3 domain of GRB2 
(Fig.  3 B). 
Myr 3 Is Expressed in Many Tissues and Cell Lines 
Northern blot analysis of poly(A)  + RNA from neonatal and 
adult rat tissues revealed a  message size of 5.1  kb.  Myr 3 
message was detected in several tissues (Fig. 4), such as neo- 
natal kidney, lung, and intestine, as well as in adult lung and 
spleen. 
Antisera  raised  against  synthetic peptides  and  a  fusion 
protein encompassing various regions of myr 3 (see Mate- 
rials and Methods) specifically recognized a protein of 126 
kD in several rat tissues and cell lines of rat, mouse, dog, 
and human origin (Figs. 5 and 6 and data not shown). This 
molecular mass  is  in  good agreement with the calculated 
mass from the deduced amino acid sequence of 126.8 kD. In 
some tissues and cell lines, anti-myr 3 antibodies also recog- 
nized a band of 110 kD. This band became more evident with 
time of storage, and at the same time, the band at  126 kD 
decreased in intensity (Fig.  7 A).  This result strongly sug- 
gested that the 110-kD band represents a degradation prod- 
uct. Indeed, antibodies directed against the COOH-terminal 
SH3 domain did not recognize the 110-kD band, demonstrat- 
ing that myr 3 was degraded from the COOH terminus (Fig. 
7 A). The relative amount of myr 3 degradation strongly de- 
pended on the source of tissue. Rapid degradation was ob- 
served in spleen (Fig. 7 A), whereas myr 3 degradation was 
less pronounced in lung tissue (Fig. 7, B and C). In conclu- 
sion, myr 3 exhibited a  widespread distribution. 
Loss of a COOH-terminal Fragment Influences 
Solubilization and F-Actin Binding of Myr 3 
Upon homogenization of rat lung tissue, the bulk of myr 3 
was recovered in the soluble fraction and a smaller amount 
was found in the particulate fraction (Fig. 7 B). The reverse 
distribution was observed for a  ll0-kD NH2-terminal frag- 
ment that is missing part of the COOH-terminal tail region, 
including the SH3 domain (Fig. 7, A and B). This ll0-kD 
NH2-terminal fragment was  more abundant in the particu- 
late fraction, from which it was released by Mg-ATP.  This 
result  suggested  that  in  tissue  homogenates  the  ll0-kD 
The Journal of Cell Biology, Volume  129, 1995  822 Figure 4.  Message size and expression pattern of myr 3  mRNA. 
Northern blots (1 ~g of poly(A)  + RNA per lane) were hybridized 
with the PCR fragment 13/14-1. The position of the 5.1-kb myr 3 
mRNA is indicated on the right; size standards are on the left. The 
tissues used were kidney (lane 1 ), lung (lane 2), and intestine (lane 
3) from neonatal rats and spleen (lane 4) and lung (lane 5) from 
adult rats. 
Figure  5.  Tissue distribution of 
myr 3. Equal amounts of protein 
from  the  indicated tissues  were 
separated on SDS-PAGE and im- 
munohlotted  with  the  aflinity- 
purified antibody Tfi 58 followed 
by a secondary antibody coupled 
to alkaline phosphatase. The po- 
sition of myr 3 is indicated on the 
right;  molecular mass standards 
are on the left. Tissues are indi- 
cated above each lane. 
Stfl~er et al. Mammalian Myosin l  823 Figure 6. Expression ofmyr 3 in different cell lines. (A) Equal amounts of  protein from the indicated cell lines were separated on SDS-PAGE 
and immunoblotted with the afffinity-purified  antibody T/i 41. (B) Homogenate from NRK cells was separated on SDS-PAGE and immuno- 
blotted with the affinity-purified  antibody FML 6. The primary antibody was followed  by a secondary antibody coupled to alkaline phospha- 
tase. The position of myr 3 is indicated on the right; molecular weight standards are on the left. Cell lines are indicated on top of each 
lane. MDCK, Madin-Darby canine kidney cells; Neuro-2a, mouse, neuroblastoma; HT29, human, colon adenocarcinoma; N63, human, 
glioblastoma; A431, human, epidermal carcinoma; PC12, rat, adrenal phaeochromocytoma; NMU, rat, breast adenocarcinoma; C6, rat, 
glial tumor; HepG2, human, liver tumor; P388D1, mouse, monocyte-macrophage; IC21, mouse, macrophage; NRK, rat, kidney fibroblast. 
NH2-terminal fragment, but not intact myr 3,  was binding 
in an ATP-regulated manner to F-actin. 
To test this suggestion directly, the soluble fraction was in- 
cubated in the presence or absence of polymerized actin and 
ATP, respectively. As demonstrated in Fig. 7 C, the ll0-kD 
NH2-terminal fragment cosedimented in an ATP-regulated 
manner with F-actin, whereas intact myr 3 showed virtually 
no ability to cosediment with F-actin.  This result demon- 
strated that in tissue homogenates the COOH terminus of 
myr 3 was inhibiting the ATP-regulated F-actin binding ac- 
tivity of myr 3. 
Myr 3 Is Associated with Calmodulin 
To identify the putative light chain associated with myr 3, we 
performed immunoprecipitation experiments.  Antisera TO 
57 and FML 6 were shown to precipitate myr 3 under non- 
denaturing conditions. Antiserum TO 41 reacted with myr 3 
on immunoblots but was unable to precipitate myr 3 under 
nondenaturing conditions (Fig.  8 A).  Immunoprecipitation 
experiments with antisera TO 57 and FML 6 (but not T/i 41) 
from [35S]methionine-labeled  NRK and C6 cells led to the 
coprecipitation of a  band comigrating with authentic  cal- 
modulin (data not shown). To probe directly for coprecipita- 
tion of calmodulin  with  myr 3,  immunoprecipitates from 
lung  tissue  were  analyzed by  immunoblotting  with  anti- 
calmodulin antibodies. In immunoprecipitates of myr 3 with 
antibodies TO 57 and FML 6,  a  band exhibiting the Ca  2+- 
dependent  mobility  shift on  SDS-PAGE  characteristic  of 
calmodulin was recognized by the anti-calmodulin antibody 
(Fig. 8 B). This result strongly suggested that myr 3 was as- 
sociated with calmodulin. 
To test directly whether myr 3  is  a  calmodulin-hinding 
protein,  gel  overlay  assays  with  ~25I-labeled calmodulin 
were performed. Aliquots of analogous immunoprecipitates 
probed with the anti-calmodulin antibody were separated on 
SDS-PAGE and  incubated with  tESI-labeled calmodulin  in 
the presence (0.1 mM CaCI~) or absence (3 mM EGTA) of 
free Ca  2÷ (Fig. 8 C).  z25I-labeled  calmodulin interacted with 
myr 3 in both the presence and absence of free Ca  2÷, as is 
characteristic of myosin light chains. 
Intracellular Localization  of  Myr 3 
To determine the intracellular localization of myr 3, indirect 
immunofluorescence experiments were performed with NRK 
cells.  Indirect immunofluorescence staining obtained with 
the FML 6 antibody, which is highly specific for myr 3 in 
NRK cells, (Fig. 6 B) is shown. This anti-myr 3 antibody 
prominently  stained  short,  elongated  structures  located 
close to sites of cell-cell contacts (Fig.  9,  A,  C,  and E). 
These myr 3-positive structures were found only at a subset 
of cell-cell contacts, indicating that they might form tran- 
siently  during  cell-cell  contact  formation.  Besides  these 
prominently labeled structures, a general punctate staining 
of the cytoplasm was also observed (Fig. 9).  Antibody T/i 
58, which was raised against a synthetic peptide derived from 
an actin-binding region in the head domain, gave a similar 
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fragment. (A) Myr 3 is rapidly degraded in spleen tissue to a 110- 
kD fragment  lacking  the  COOH-terminal  SH3  domain.  Spleen 
from adult rats was homogenized in 0.32 M sucrose, 5 mM Hepes, 
pH 7.4, and incubated at room temperature. At various time points, 
indicated above each lane, samples were collected and analyzed by 
immunoblotting  with  antibodies  Tii 41  (top panel)  and  FML5 
affinity-purified over a  GST-SH3  fusion protein  (bottom panel). 
The arrows on the right indicate the positions ofmyr 3 and its ll0- 
kD degradation product;  molecular mass standards are shown on 
the left.  (B) Different solubilization properties  of myr 3 and the 
ll0-kD NH:-terminal  fragment.  Lung tissue from adult rats was 
homogenized in a buffer containing 20 mM Hepes, pH 7.4, 10 mM 
MgCI2,  1 mM 2-mercaptoethanol,  0.1  mM EGTA, and  100 mM 
NaCI (H) and centrifuged to obtain supernatant (S) and pellet (P). 
The pellet was extracted with the same buffer containing 5 mM ATP 
(E). The obtained fractions were analyzed for myr 3 distribution 
by immunoblotting with antibody  Tii 41.  (C) The  ll0-kD NHz- 
terminal fragment but not intact myr 3 binds in an ATP-regulated 
manner to F-actin.  Lung tissue from adult rats was homogenized 
in 0.32 M sucrose,  5 mM Hepes,  pH 7.4, and centrifuged.  The 
supernatant  was incubated in the absence (-) or presence  (+) of 
actin  (5 /zM) and ATP (2 mM). F-actin binding was assayed by 
cosedimentation  with  F-actin.  Supernatants  (S)  and  pellets  (P) 
were analyzed by immunoblotting with antibody TO 41. 
staining pattern. However, the elongated structures at cell- 
cell contacts were less prominently stained (data not shown). 
To characterize these myr 3-positive structures  at cell- 
cell contacts, double immunofluorescence experiments were 
performed.  Because myr 3  is postulated to produce force 
along actin filaments, cells were simultaneously labeled for 
myr 3 and F-actin (Fig. 9, A and B). The structures labeled 
with  anti-myr  3  antibody  were  also positive for F-actin. 
However, these structures represented only a fraction of the 
total F-actin present in a cell. The individual structures con- 
taining myr 3 and F-actin exhibited the appearance of cross- 
linked  actin  filaments.  Therefore,  double  immunofluores- 
cence staining for myr 3 and the F-actin cross-linking protein 
a-actinin were performed (Fig. 9,  C and D). These experi- 
ments demonstrated that the structures labeled by anti-myr 3 
antibodies at cell-cell contacts were also labeled by antibod- 
ies  against  c~-actinin.  These  results  suggested  that  myr 3 
colocalizes with actin filament-a-actinin networks at sites of 
cell-cell  contact.  Because  the  myr  3-positive  structures 
were reminiscent of focal adhesions,  we performed double 
immunofluorescence experiments with an antibody directed 
against vinculin, an essential component of focal adhesions. 
As shown in Fig.  9, E  and F, the myr 3-positive structures 
did not colocalize with focal adhesions when stained by anti- 
vinculin  antibodies  and  therefore  did  not  represent  focal 
adhesions. 
Since myr 3 is enriched in presumably transient structures 
at sites of cell-cell contact, we reasoned that this localization 
might be regulated by cell surface receptors. To test this pos- 
sibility,  NRK  cells  were  incubated  with  the  plant  lectin 
Con A. Con A binds tightly to mannose and glucose moie- 
ties of cell surface receptors and activates them upon bind- 
ing.  A  dramatic  induction  of  myr  3  localization  along 
cell-cell contacts was observed as a consequence of Con A 
treatment of NRK ceils (Fig. 10). Whereas in untreated cells 
myr 3-containing structures at sites of cell-cell contact were 
only occasionally observed, in Con A-treated cells myr 3 
staining outlined cell-cell borders in a  zipper-like appear- 
ance.  The  organization  of F-actin  was  also  modulated  in 
Con A-treated  cells,  and  similar  structures  colocalizing 
with myr 3 were observed along cell-cell borders (Fig.  10, 
A and B). There were no myr 3-positive structures induced 
with Con A  at sites other than cell-cell borders. In control 
experiments we found that application of Con A did not re- 
sult in the relocalization of two other myosin I  molecules, 
namely myr 1 and myr 2, to these structures.  In summary, 
myr 3  was concentrated  in  Con A-inducible  F-actin-rich 
structures at regions of cell-cell contact. 
Discussion 
Our identification of a mammalian myosin I related to myo- 
sin  I  molecules from protozoa demonstrates a  ubiquitous 
distribution for this subfamily of myosin I proteins and im- 
plies that they are of general importance for cellular func- 
tion. This is a notion strengthened by the recent deposition 
of the sequence for chicken brush border myosin IB in the 
database by A. E. Knight and J. Kendrick-Jones (accession 
number X70400) and the cloning of human myosin IC (Be- 
ment et al.,  1994b).  Whereas human myosin IC represents 
the human homolog of rat myr 3, chicken brush border myo- 
sin IB is more likely a direct homolog of a different human 
St6ffier et al. Mammalian Myosin 1  825 Figure 8. Coprecipitation of calmodulin with myr 3 and direct binding of calmodulin to myr 3. Myr 3 was immunoprecipitated from adult 
rat lung tissue homogenates with affinity-purified anti-myr 3 antibodies Tii 41, Tti 57, and FML 6; immunoprecipitation only with protein 
A-Sepharose beads served as a control. (A) Immunoprecipitates were separated on SDS- PAGE, and proteins were stained with Coomassie 
brilliant blue. The arrow on the right indicates the position of myr 3; molecular mass standards are shown on the left. The antibodies 
used are indicated above each lane. (B) Immunoprecipitates  were boiled with 5x Laemmli buffer in the presence (C) or absence (E) of 
free Ca  a+, separated on SDS-PAGE, and inununoblotted with an anti-calmodulin antibody followed by a secondary antibody coupled to 
peroxidase. The two arrowheads on the right indicate the relative positions of authentic calmodulin in the presence (bottom arrowhead) 
and absence (top arrowhead)  of free Ca  2+. Protein standards are indicated on the left, and the antibodies used for immunoprecipitation 
are above each lane.  (C) Immunoprecipitates  identical to those in A were separated on SDS-PAGE and incubated with ~25I-calmodulin 
in the presence (top  panel; Ca) or absence (bottom  panel; EGTA)  of free Ca  2÷. The autoradiographs  are shown. Protein standards are in- 
dicated on the left; the antibodies used for immunoprecipitation  are above each lane. 
myosin I, myosin ID (Bement et al.,  1994a),  and therefore 
is not the direct chicken homolog of rat myr 3. Thus, amoe- 
boid myosin I  molecules are not restricted to protozoa. 
The motor activity of protozoan myosin I molecules is ac- 
tivated by phosphorylation of a single serine/threonine resi- 
due in the head region (Maruta and Korn, 1977;  Brzeska et 
al.,  1989).  This region of the head is proposed to be part 
of the  primary  actin-binding  site  (Rayment et  al.,  1993; 
Schrfder et al.,  1993). A consensus sequence that serves as 
a substrate recognition motif for the myosin I heavy chain ki- 
nase has been determined (Brzeska et al., 1990). The corre- 
sponding region in myr 3 does not conform to this consensus 
phosphorylation sequence.  It contains  at the position of a 
serine or threonine  residue  a  negatively charged glutamic 
acid residue, as is also found in conventional myosin. This 
negatively charged residue might substitute for the negative 
charge introduced by a phosphate group. It is therefore likely 
that myr 3 motor activity, as in conventional myosin, is regu- 
lated by other means. Two possibilities may represent regu- 
lation through the light chain in the neck region and/or the 
SH3 domain at the COOH terminus. 
In this  report we  demonstrated that  upon  immunopuri- 
fication of myr 3,  the  Ca2+-binding  protein calmodulin  is 
copurified and that purified myr 3 can bind calmodulin in gel 
overlay assays. These data strongly suggest that one calmed- 
ulin molecule is associated with the single light chain-bind- 
ing  site  (IQ motif)  present  in  myr  3.  The  association  of 
calmodulin  with  myr 3  and the binding  of calmodulin to 
myr  3  were  not  dependent  on  free  Ca  2÷  concentrations, 
which is consistent with the notion that calmodulin acts as 
a  light chain  and  binds  to  the  IQ motif.  IQ motifs were 
reported  to  bind  calmodulin  even in  the  absence  of free 
Ca  2+  (Halsall  and  Hammer,  1990).  Calmodulin  has  been 
demonstrated to serve as the light chain for several uncon- 
ventional myosin molecules, including other vertebrate myo- 
sin  I  molecules.  However,  calmodulin  has  not  yet  been 
reported to act as the light chain for amoeboid myosin I mol- 
ecules. Purified myosin IB from Acanthamoeba  was reported 
to contain a single light chain of 27 kD (Maruta et al., 1978), 
and myosin IC contains two light chains of 14 kD (Lynch et 
al.,  1989). These molecular masses are at variance with the 
molecular mass of calmodulin,  which  is  17 kD.  The pro- 
The Journal of Cell Biology, Volume  129, 1995  826 Figure 9.  Double immunofluorescence localization of myr 3 with F-actin, ~actinin, and vinculin in NRK cells. Cells were fixed with 4% 
paraformaldehyde, permeabilized with 0.1% saponin, and stained with the rabbit anti-myr 3 antibody FML 6 (A, C, and E) followed by 
rhodamine-coupled goat anti-rabbit antibody. Double staining was performed with FITC-coupled phalloidin (B), mouse anti-~-actinin 
antibody (D), and mouse anti-vinculin antibody (F) followed by FITC-coupled goat anti-mouse antibody. The arrows point to regions of 
elongated structures enriched in myr 3. These structures were also detected to contain F-actin (.4 and B) and a-actinin (C and D), but 
not vinculin (E and F). Bars,  10 t~m. 
St6fl]er et al. Mammalian Myosin !  827 Figure  10.  Con  A-induced 
myr 3 localization at cell-ceU 
boundaries  in  NRK  cells. 
NRK cells were incubated for 
30 rain with PBS in the pres- 
ence (,4 and B) or absence (C 
and D) of  Con A (5 t~g/ml)  and 
then  fixed with 4%  parafor- 
maldehyde,  permeabilized 
with  0.1%  saponin,  and 
stained  with  the  rabbit 
anti-myr 3 antibody FML 6 
followed  by  rhodamine- 
coupled goat anti-rabbit anti- 
body  (A  and  C)  and  with 
FITC-coupled  phalloidin  (B 
and D). The arrows in A and 
B point to cell boundaries that 
are  outlined by myr 3-  and 
F-actin-positive structures af- 
ter  treatment  with  Con  A. 
Bars, 10 #m. 
posed difference in the mechanism(s) regulating motor activ- 
ity of  protozoan myosin I molecules and ofmyr 3 might have 
caused the need for different light chains.  Instead of being 
regulated by phosphorylation of  the head region, myr 3 could 
be regulated by Ca  :+ binding to calmodulin. This possibil- 
ity is  not unprecedented.  Ca  2÷ has  been demonstrated to 
regulate motility of brush border myosin I  and myosin V, 
both of which have calmodulin as light chains associated 
with them (Collins et al.,  1990; Cheney et ai.,  1993). 
The SH3 domain found at the COOH terminus of myr 3 
represents another domain possibly involved in the regula- 
tion of myr 3 function. SH3 domains have been reported to 
act and interact intramolecularly and to be masked until acti- 
vation exposes them  for interaction with  a  target protein 
(Murphy et al.,  1993; Okada et ai.,  1993;  Superti-Furga et 
al., 1993). Indeed, the myr 3 tail region exhibits proline-rich 
sequences that could possibly interact with the SH3 domain. 
Proline-rich sequences have recently been demonstrated to 
serve as ligands for several SH3 domains (Cicchetti et al., 
1992; Ren et al.,  1993). In favor of such a hypothesis is our 
finding that most myr 3 is cytosolic after cell homogeniza- 
tion and does not seem to be able to interact with actin illa- 
ments.  However, a  breakdown product of myr 3  (ll0-kD 
NH2-terminal fragment) that has lost its SH3 domain is in- 
teracting with actin filaments in an ATP-regulated manner. 
Therefore, the SH3 domain might also be a candidate region 
for regulating myr 3 activity. 
The SH3 domain of myr 3 might alternatively or in addi- 
tion serve as a regulatory targeting module for myr 3 local- 
ization.  It  was  recently reported that the  SH3  domain of 
fodrin localizes to the leading lamellae of locomoting fibro- 
blasts  (Meril~iinen  et al.,  1993)  and that the two SH3 do- 
mains of GRB2 are necessary for the localization of micro- 
injected  GST-GRB2  fusion  protein  to  membrane  ruffles 
(Bar-Sagi et al.,  1993). 
Immunofluorescence localization of myr 3 in NRK cells 
revealed a punctate cytosolic staining in all cells and a prom- 
inent staining of distinct elongated structures at occasional 
sites of cell-cell contacts. The punctate staining seemed to 
be homogeneously distributed  throughout  the  cytoplasm. 
This cytoplasmic staining may represent a pool of inactive 
myr 3 that in response to a certain stimulus (see below) may 
be recruited to the elongated structures in regions of  cell-cell 
contact. Support for this hypothesis is provided by our obser- 
vation that the punctate staining of myr 3 is reduced around 
the elongated structures containing myr 3. 
The  elongated  structures  at  sites  of  cell-cell  contact 
stained by anti-myr 3 antibodies were enriched for F-actin 
and et-actinin. Therefore, these structures consist of cross- 
linked actin filament networks. However, these myr 3-pos- 
itive structures do not represent focal adhesions because no 
colocalization with vinculin, a marker for focal adhesions, 
could be observed.  It  remains to be determined whether 
myr 3 is part of the actin network and may cross-link and 
move actin filaments relative to each other by interacting 
through its tail domain with actin or an actin-associated pro- 
tein or whether myr 3 is associated with a membrane protein 
that might get drawn to this actin-rich structures by myr 3. 
The myr 3 tail domain contains a region that is homologous 
to a  region in amoeboid myosin I molecules implicated in 
membrane binding (Doberstein and Pollard, 1992) but con- 
tains no extended glycine/proline-rich region implicated in 
nucleotide-insensitive  actin  binding  (Jung  and  Hammer, 
1994; Rosenfeld and Rener,  1994). 
Myr 3 is related to myosin IB proteins from A. castellanii 
and D. discoideum. The Iocaiizations reported for these pro- 
tozoan myosin I molecules differed from the localization of 
myr 3. Myosin IB from Acanthamoeba has been localized to 
the  plasma  membrane,  large  vacuole membranes,  phago- 
cytic membranes, and cytoplasm (Baines et al., 1992). Myo- 
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and phagocytic cups (Fukui et al., 1989; Jung et al., 1993). 
No particular staining  of the leading edge or the plasma 
membrane using antibodies against myr 3 was detected in 
NRK ceils. These differences in localization between myr 3 
and homologous protozoan myosin I molecules might repre- 
sent functional adaptations to a multicellular organism. In- 
terestingly,  expression of Dictyostelium  myosin IB  is  in- 
creased  severalfold  upon  starvation-induced  chemotactic 
aggregation (Jung et al.,  1989a). Localization of a myosin I 
at cell-cell contacts,  however, is  not unprecedented since 
myosin IA from A. castellanii, from which no complete se- 
quence has been determined, has been found at phase-dense 
cortical structures at sites of  cell-ceU contact (Yonemura and 
Pollard,  1992). 
Treatment of NRK cells with Con A resulted in a dramatic 
induction of myr 3- and F-actin-positive structures along 
cell-cell contacts exhibiting a zipper-like appearance. The 
induced structures resembled the myr 3-containing struc- 
tures  in  untreated  cells  but  were  on  average  somewhat 
shorter.  The  restriction  of these  structures  to  areas  of 
cell-cell contact independently of Con A treatment implies 
that Con A  enhances a  physiologic signal.  It is not clear 
whether recruitment of myr 3 represents the cause for these 
structures  or  the  consequence of the  formation of these 
F-actin-containing structures. However, it seems likely that 
myr 3 function is regulated by cell surface-mediated signal- 
ing events possibly involving the SH3 domain in the myr 3 
tail. It remains to be determined whether myr 3 plays a role 
in promoting or inhibiting cell-cell contact formation. 
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